AstraZeneca PLC
5 February 2002
DEALING BY DIRECTORS
COMPANIES ACT 1985 SECTION 324/329
WE HEREBY INFORM YOU THAT ON 4 FEBRUARY 2002 THE FOLLOWING DIRECTORS OF THE
COMPANY ACQUIRED AN INTEREST IN ASTRAZENECA PLC ORDINARY SHARES OF USD0.25 EACH.
THE INTERESTS ARISE AS A RESULT OF AN AUTOMATIC RELEASE OF SHARES OUT OF
RETENTION UNDER THE ASTRA GLOBAL PROFIT SHARING SCHEME. UNDER THE RULES OF THE
SCHEME, SHARES ARE PLACED IN TRUST AND ARE NOT BENEFICIALLY OWNED BY THE
PARTICIPANT WHILE THEY REMAIN HELD IN THE TRUST. THE PARTICIPANT CAN MAKE AN
ANNUAL ELECTION TO WITHDRAW THE SHARES OUT OF TRUST AT WHICH TIME THE
PARTICIPANT BECOMES THE BENEFICIAL OWNER OF THE SHARES. THE RELEASE DATE IS
USUALLY IN THE LAST WEEK OF JANUARY OR THE FIRST WEEK OF FEBRUARY EVERY YEAR,
THE ELECTION HAVING BEEN MADE IN AUGUST OF THE PREVIOUS YEAR.
NAME OF DIRECTOR NUMBER OF SHARES TOTAL INTEREST PERCENTAGE OF ISSUED
SHARES
A B T STAVLING 94 9,023 0.001
C E WILHELMSSON 188 27,650 0.002
THE SHARES ARE REGISTERED IN THE DIRECTORS' VPC ACCOUNTS IN SWEDEN. THE PRICE OF
ORDINARY SHARES OF ASTRAZENECA PLC AT CLOSE OF BUSINESS ON 4 FEBRUARY 2002 WAS
3345P.
G H R MUSKER
COMPANY SECRETARY
5 FEBRUARY 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.